{"result": {"id": "5654ccd7-40e0-48d7-ae6c-678cde08f1e9", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>辛伐他汀<|>PERSON<|>辛伐他汀是一种常用的他汀类药物，用于降低血清低密度脂蛋白浓度，轻度升高高密度脂蛋白水平，疗效肯定。商品名为舒降之。)\n##\n(\"entity\"<|>普伐他汀<|>PERSON<|>普伐他汀是一种常用的他汀类药物，用于降低血清低密度脂蛋白浓度，轻度升高高密度脂蛋白水平，疗效肯定。)\n##\n(\"entity\"<|>洛伐他汀<|>PERSON<|>洛伐他汀是国际上公认的降胆固醇较好的药物，通常剂量为20毫克/次，每天1-2次。)\n##\n(\"entity\"<|>阿托伐他汀<|>PERSON<|>阿托伐他汀是最新一代的他汀类药物，具有降低胆固醇和三酰甘油的作用，通常剂量为10毫克/次，每天1次。)\n##\n(\"entity\"<|>非诺贝特<|>PERSON<|>非诺贝特是一种贝特类药物，用于以三酰甘油升高为主的高脂血症，通常剂量为0.1克/次，每天2次，停药后有时会有反弹。)\n##\n(\"entity\"<|>吉非罗齐<|>PERSON<|>吉非罗齐是一种贝特类药物，用于以三酰甘油升高为主的高脂血症。)\n##\n(\"entity\"<|>高脂血症<|>EVENT<|>高脂血症是一种血脂异常疾病，确诊后首先应进行非药物治疗，包括饮食调整、生活方式改善以及影响因素的控制。)\n##\n(\"entity\"<|>冠心病<|>EVENT<|>冠心病是一种心血管疾病，降脂治疗在其防治中意义重大，已被列入冠心病的三大现代疗法之一。)\n##\n(\"entity\"<|>动脉粥样硬化<|>EVENT<|>动脉粥样硬化是一种血管疾病，与高脂血症、高血压、吸烟、糖尿病等危险因素相关。)\n##\n(\"relationship\"<|>辛伐他汀<|>高脂血症<|>辛伐他汀用于治疗高脂血症，降低血清低密度脂蛋白浓度。<|>8)\n##\n(\"relationship\"<|>普伐他汀<|>高脂血症<|>普伐他汀用于治疗高脂血症，降低血清低密度脂蛋白浓度。<|>8)\n##\n(\"relationship\"<|>洛伐他汀<|>高脂血症<|>洛伐他汀用于治疗高脂血症，降低胆固醇水平。<|>8)\n##\n(\"relationship\"<|>阿托伐他汀<|>高脂血症<|>阿托伐他汀用于治疗高脂血症，降低胆固醇和三酰甘油水平。<|>8)\n##\n(\"relationship\"<|>非诺贝特<|>高脂血症<|>非诺贝特用于治疗以三酰甘油升高为主的高脂血症。<|>8)\n##\n(\"relationship\"<|>吉非罗齐<|>高脂血症<|>吉非罗齐用于治疗以三酰甘油升高为主的高脂血症。<|>8)\n##\n(\"relationship\"<|>高脂血症<|>冠心病<|>高脂血症是冠心病的危险因素之一，降脂治疗在冠心病防治中意义重大。<|>7)\n##\n(\"relationship\"<|>高脂血症<|>动脉粥样硬化<|>高脂血症是动脉粥样硬化的危险因素之一。<|>7)\n##\n(\"relationship\"<|>冠心病<|>动脉粥样硬化<|>冠心病与动脉粥样硬化密切相关，动脉粥样硬化是冠心病的主要病理基础。<|>8)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166031, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 804, "prompt_tokens": 2403, "total_tokens": 3207, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 611}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 他汀类明显降低 血清低密度脂蛋白浓度，同时轻中度降低三酰甘油以及轻度升高 高密度脂蛋白水平，疗效肯定，常用辛伐他汀（舒降之）、普伐他汀 及洛伐他汀等。贝特类用于以三酰甘油升高为主型，常用非诺贝 特、吉非罗齐等。\n　　员）洛伐他汀：是国际上公认降胆固醇较好的药物，圆园毫克辕 次，每天 员～圆次。最新一代的阿托伐他汀具有降胆固醇和三酰甘  油的作用，员园毫克辕次，每天 员次。\n　　圆）非诺贝特：对降低胆固醇和三酰甘油都有效，一般为 园援员 克辕次，每天 圆次，停药后有时会有反弹。\n　　　当高脂血症被确诊后，首先应进行非药物治疗，包括饮食调 整、生活方式改善以及影响因素的控制。在此基础上，进行药物治\n                                                     \n\n\n\n\n\t 四、正确认识高脂血症         \n疗。用药中应注意以下几点：①防治结合，非药物与药物应用相结\n合。②据高脂血症种类不同而辨型用药。 ③冠心病病人的合适血 脂水平应较低于正常人，并尽早用药，控制其他危险因素。 ④长效 降脂药，宜每晚服用 员次。⑤用药后，至少每 猿～远个月复查血脂， 肝、肾功能等，随时调整用药剂量，监测不良反应。 ⑥持续服药，以 使血脂水平控制在正常范围内。\n　　　目前，降脂治疗在冠心病防治中意义重大，已被列入冠心病的 三大现代疗法 粤月悦（粤：阿司匹林，月：β 受体阻滞剂，悦：降胆固醇） 之一，它对人类的巨大贡献不亚于当年青霉素的发现。\n摇摇圆园援掌握衡量血脂的“三把尺子”\n　　衡量成人血脂水平不像白细胞、红细胞等，只有一个标准，目 前来看，至少有 猿把尺子：①无冠心病或其他动脉粥样硬化，也无 冠心病或其他动脉粥样硬化危险因素者用第 员把尺子；②无冠心 病或其他动脉粥样硬化，但有冠心病危险因素的用第 圆把尺子；③ 有冠心病或其他动脉粥样硬化的用第 猿把尺子。\n　　通常，冠心病或其他动脉粥样硬化危险因素有： ①可以改变的 危险因素：高脂血症、高血压、吸烟、糖尿病；②不可改变的危险因 素：年龄大、男性、女性绝经期后、冠心病家族史（指直系亲属中有 冠心病史，尤其有 缘岁前早发冠心病的男性、远缘岁前发病的女性 者）。�\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_baffe3645536b9835cd61e9c236e3ed43b15c10f1f556dc2eb25c0ea4974bd74_v2"}